The FDA did not respond to a request for comment. U.S. Health Secretary Robert F. Kennedy Jr. has said that the agency's ...

The one-off treatment highlights the promise of a new type of gene editing and the challenges of using it to treat extremely ...

Some biotech executives spoke about early-stage testing on condition of anonymity to avoid drawing attention to their companies or risking retribution for criticising the Trump administration.

IO Biotech was named to Fast Company’s World’s Most Innovative Companies of 2025 list for its potentially game-changing approach to immune-modulatory cancer vaccines, earning its place on the coveted ...

So, the narrative around biotech stocks—drug developments and ... The portfolio is not one that would draw in income investors, considering the low yield. So, without a sturdy growth story ...

Our exclusive poll captures today's top trends and perspectives—shaped by those pharma decision-makers impacted the most.

The talk over the new trade deal between India and the US must be seen beyond the trade and tariffs. The reduced tariffs, lesser barriers and regulations could be a potential for economies like ...

Money flows out of Harvard into biotechs, housing projects, and retail storefronts. The school powers hospitals, tourism, and ...

A new AI tool bills itself as a hallucination-free language model for enterprises. | The model promises many benefits: no ...

Amy Parison, who stepped into the lead financial role at the company in March, is managing Editas Medicine’s transition to a new gene editing platform while recovering from a major overhaul.